Estrogen Receptor (ER) IHC Test | Lahalak Platform
An essential test for breast cancer patients to determine hormone dependency, enabling targeted hormonal therapies and significantly improving recovery chances.
Scientific name: Immunohistochemistry: Estrogen Receptor (ER)
Immunohistochemical (IHC) testing for estrogen receptor (ER) aims to detect the presence of ER proteins within the nuclei of cancer cells in breast tissue and other tissues. The result of this test (positive or negative) determines whether the breast cancer is "hormone-dependent" and, consequently, its responsiveness to anti-estrogen hormonal thera...
Service type
Histopathology Laboratory Test
Duration
30-45 minutes
Fasting
Fasting is not required
Included Services
- Detailed analysis to detect the estrogen receptor (ER) in breast cancer tissue
- Consult a pathologist or oncologist to interpret the results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- Fasting is not required, as the sample is tissue (biopsy or excision).
- The tissue sample must be immediately preserved in 10% standard neutral formalin for 6-72 hours to ensure optimal fixation (this is a critical condition for the accuracy of the results).
- The sample must be identified as cancerous breast tissue for the purpose of analysis.
- This analysis is required mandatorily along with PR and HER2 as part of the basic package for breast cancer characterization.
Medical services you might also like
